Some mechanisms of inflammation development in type 2 diabetes mellitus

Código QR

Some mechanisms of inflammation development in type 2 diabetes mellitus

Inflammation plays a key role in the development and progression of type 2 diabetes (T2DM), a disease characterized by peripheral insulin resistance and systemic glucolipotoxicity. The main source of inflammation in the early stages of the disease is visceral adipose tissue (VT). Macrophages are inn...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	L. A. Bochkareva, L. V. Nedosugova, N. A. Petunina, M. Е. Теlnova, E. V. Goncharova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2021
Materias:	inflammation type 2 diabetes mellitus insulin resistance adipose tissue macrophages Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/2118aaf5687d482aac22da2051bc2cc7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Metabolic characteristics and therapeutic potential of brown and ?beige? adipose tissues
por: Ekaterina Olegovna Koksharova, et al.
Publicado: (2014)

Insulin-induced lipohypertrophy: clinical and ultrasound characteristics
por: Vadim V. Klimontov, et al.
Publicado: (2018)

Markers of inflammation in patents with type 2 diabetes and cardiovascular form of diabetic autonomous neuropathy
por: Irina Arkad'evna Bondar', et al.
Publicado: (2009)

Diabetes mellitus due to biliary recurrent pancreatitis. Case report
por: Elena Alexandrovna Kharlashina, et al.
Publicado: (2011)

Lipid profile and markers of vascular inflammation in patients with stable angina in the presence and absence of type 2 diabetes mellitus
por: Tatiana I. Petelina, et al.
Publicado: (2017)

Lipodystrophy at the insulin injection sites: current trends in epidemiology, diagnostics and prevention
por: Vadim V. Klimontov, et al.
Publicado: (2020)

Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment
por: Tatiana Ivanovna Romantsova, et al.
Publicado: (2013)

Diabetes mellitus and pyoinflammatory diseases of ENT organs
por: Elena Valer'evna Biryukova, et al.
Publicado: (2012)

Humalog Mix 25 in the treatment of type 2 diabetes mellitus
por: Vladimir Ivanovich Zoloedov, et al.
Publicado: (2012)

Statin use and risk of diabetes mellitus
por: Oksana Mikhailovna Drapkina, et al.
Publicado: (2012)

Overcoming marked insulin resistance in a patient with type 2 diabetes mellitus by means of insulin pumptherapy
por: Ekaterina Viktorovna Artemova, et al.
Publicado: (2012)

The role of lipid droplets in the emergence of diabetes mellitus type 2
por: L. V. Astakhova, et al.
Publicado: (2020)

Insulin therapy during pregnancy in women with type 1 diabetes
por: V V Potin, et al.
Publicado: (2009)

Birth weight and length in offsprings of mothers with gestational diabetes mellitus due to mutations in GCK gene
por: Natalia A. Zubkova, et al.
Publicado: (2018)

When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
por: Elena V. Buryukova, et al.
Publicado: (2017)

Harold Himsworth, founder of diabetes classification: 105th anniversary of his birthday
por: Olga Sergeevna Fedorova
Publicado: (2010)

Risk of oncological diseases in patients with diabetes mellitus
por: Gagik Radikovich Galstyan
Publicado: (2009)

Priority areas in management of diabetes mellitus type 1 & 2 (following 47th EASD Annual Meeting)
por: Ivona Renata Yarek-Martynova, et al.
Publicado: (2011)

Heart failure and diabetes mellitus: insight into comorbidity
por: Nina A. Petunina, et al.
Publicado: (2019)

Telomere length and vascular wall in patients with Type 2 Diabetes Mellitus
por: Ekaterina Nailyevna Dudinskaya, et al.
Publicado: (2014)

Sulfonylureas in the modern strategy of therapy of type 2 diabetes
por: Lyudmila Viktorovna Nedosugova
Publicado: (2011)

Pleiotropic effects of fenofibrate: focus on type 2 diabetes mellitus
por: Alexander Sergeevich Ametov, et al.
Publicado: (2014)

Lypohypertrophy in patients receiving insulin therapy: state of the art
por: Natalya Ivanovna Volkova, et al.
Publicado: (2011)

Modern Understanding of the Gut Microbiotа in Patients with Diabetes Mellitus
por: E. V. Chugunova, et al.
Publicado: (2021)

Functional activity and peripheral insulin resistance in patients with different types of onset of diabetes mellitus
por: Tatiana Vasil'evna Nikonova, et al.
Publicado: (2012)

The experience with the use of insulin pump therapy in children and adolescents with type 1 diabetes mellitus
por: Nina Viktorovna Bolotova, et al.
Publicado: (2010)

Serum adipokine concentrations in patients with type 2 diabetes: the relationships with distribution, hypertrophy and vascularization of subcutaneous adipose tissue
por: Vadim V. Klimontov, et al.
Publicado: (2019)

Modern approach to basal-bolus therapy with glargine and glulisine insulin analoguesin various age groups
por: Natalya Nikitichna Volevodz, et al.
Publicado: (2013)

Selected aspects of insulin pump therapy and continuous glucose monitoring in real time (in relation to the letter of E.D.Gorbachev)
por: Yury Ivanovich Filippov, et al.
Publicado: (2010)

Insulin pump therapy in children with diabetes mellitus: practice of Krasnoyarsk Krai
por: Tatiana Evgen'evna Taranushenko, et al.
Publicado: (2012)

Risk factors for decreased bone mineral density in men with type 2 diabetes.
por: Olga N. Fazullina, et al.
Publicado: (2021)

Dose adjustment in insulin pump therapy: optimization of bolus calculator settings
por: Yury Ivanovich Filippov, et al.
Publicado: (2012)

Genetic framework of type 2 diabetes mellitus
por: Irina Arkad'evna Bondar', et al.
Publicado: (2013)

Adipose tissue alleviates the stress response by releasing adiponectin during laparoscopic surgery in patients with colorectal cancer
por: Wenjiao Shi, et al.
Publicado: (2021)

Novel approach to pathophysiology of type 2 diabetes mellitus
por: Emil' Kopeevich Mukhamedzhanov, et al.
Publicado: (2013)

Individual stepwise intensification of insulin analogue therapy in type 2 diabetes mellitus
por: Alexander Sergeevich Ametov, et al.
Publicado: (2012)

The role of coagulation and inflammation in the development of diabetic nephropathy in patients withdiabetes mellitus type 2
por: Yulia Valer'evna Khasanova, et al.
Publicado: (2012)

Insulin resistance in pathogenesis of type 2 diabetes mellitus
por: Alexander Yur'evich Mayorov
Publicado: (2011)

Treatment of helicobacter pylori contamination in patients with type 2 diabetes mellitus with gastroduodenal disorders
por: Yuri L. Fedorchenko, et al.
Publicado: (2017)

Systems of continuous subcutaneous insulin infusion to maintain metabolic compensation for type 1 diabetes mellitus among children and adolescents
por: Elena B. Bashnina, et al.
Publicado: (2019)